Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 1 (January)

1. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus.
   J Clin Endocrinol Metab, 91(1): 204-12. [Abstract] [Full-text]
2. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
   J Clin Oncol, 24(2): 252-8. [Abstract] [Full-text]
3. Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.
   Cancer Chemother Pharmacol, 57(4): 465-74. [Abstract] [Full-text]
4. Anticipating disaster: the genetics of familial pancreatic cancer.
   Gut, 55(2): 150-1. [Abstract] [Full-text]
5. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice.
   Gut, 55(2): 259-65. [Abstract] [Full-text]
6. Anticipation in familial pancreatic cancer.
   Gut, 55(2): 252-8. [Abstract] [Full-text]
7. A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest.
   Biochem Biophys Res Commun, 340(4): 1224-8. [Abstract] [Full-text]
8. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
   J Clin Oncol, 24(3): 401-6. [Abstract] [Full-text]
9. Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.
   J Clin Oncol, 24(3): 379-85. [Abstract] [Full-text]
10. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Cancer Res, 66(2): 1208-17. [Abstract] [Full-text]
11. Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.
    Cancer Res, 66(2): 1191-8. [Abstract] [Full-text]
12. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer.
    Cancer Res, 66(2): 1025-32. [Abstract] [Full-text]
13. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.
    Cancer Res, 66(2): 898-906. [Abstract] [Full-text]
14. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
    Hum Pathol, 37(2): 212-7. [Abstract] [Full-text]
15. Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe.
    Nucleic Acids Res, 34(2): e12. [Abstract] [Full-text]
16. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Radiology, 238(2): 560-9. [Abstract] [Full-text]
17. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.
    J Clin Oncol, 24(4): 656-62. [Abstract] [Full-text]
18. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
    Biochem Biophys Res Commun, 341(2): 478-82. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.